Friday, 30 March 2012 - 10:38

The Treatment Action Campaign (TAC) is deeply concerned about reports of stock shortages of the essential antiretroviral medicine, tenofovir, in the public health system. Tenofovir is part of the standard regimen prescribed to people with HIV initiating antiretroviral treatment. It is a potent suppressor of HIV with an excellent side effect profile. It is a life-saving drug and one of the most important in the public health system.


29 March 2012
The Treatment Action Campaign (TAC) is deeply concerned about...
Read more
Tuesday, 27 March 2012 - 10:01

A Treatment Action Campaign briefing document

The Agreement on Trade Related Aspects of Intellectual Property (“the TRIPS agreement”), effective from 1 January 1995, set standards of intellectual property protection that member states of the World Trade Organisation (WTO) are required to uphold in their own national laws.[1]
The TRIPS agreement requires WTO member countries to provide 20 years of patent protection on pharmaceuticals and all other products that meet patentability criteria (previously South Africa...
Read more
Tuesday, 27 March 2012 - 09:52


The National Health Laboratory Service (NHLS) is vital to our health system. It conducts virtually all diagnostics for the public health system. This also includes HIV viral loads, CD4 counts, TB culture and resistance tests.
It is a functioning institution. But it is facing bankruptcy and collapse because the Gauteng and Kwazulu-Natal Provincial Departments of Health have failed to pay it.
Funding constraints have already begun to impact the NHLS’s ability to provide quality and rapid diagnostic services.
... Read more
Tuesday, 27 March 2012 - 09:34

Today is World AIDS Day and this year we are marking 30 years since the discovery of AIDS. We can claim great successes in the response over the last decade. We have seen a shift from where people were dying with no access to treatment to about 7 million on treatment globally. But last week all that progress was put at risk.

The devastating news came that the Global Fund does not have enough money to put anyone new on HIV treatment until 2014. The failure of donors to pay their fair share of the cost of the response has forced the Fund to cancel its 11th funding...
Read more
Tuesday, 13 March 2012 - 10:17


With the global shift in funding priorities, crucial funding for HIV programmes has dwindled but the need for such funding still remains. The dwindling of funds affects many local programmes that are heavily dependent on traditional donors in order to survive and continue making a difference in saving lives through treatment and prevention of HIV and TB.

At the...

Read more